Source:http://linkedlifedata.com/resource/pubmed/id/15205117
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2004-10-11
|
pubmed:abstractText |
Sphingomyelin (SM) hydrolysis in the gut has implications in colonic tumorigenesis and cholesterol absorption. It is triggered by intestinal alkaline sphingomyelinase (Alk-SMase) that is present in the intestinal mucosa and content. The mechanism by which the enzyme is released into the lumen is not clear. We studied whether trypsin can dissociate Alk-SMase from the mucosa and affect its activity. During luminal perfusion of rat intestine, addition of trypsin to the buffer increased Alk-SMase activity in the perfusate output by about threefold. Treating COS-7 cells transfected with Alk-SMase cDNA with trypsin increased the SMase activity in the medium and reduced that in the cell lysate dose dependently. The appearance of Alk-SMase in the perfusate and culture medium was confirmed by Western blot analysis. The effect of trypsin was blocked by trypsin inhibitor, and neither chymotrypsin nor elastase had a similar effect. We also expressed the full length and COOH-terminal truncated Alk-SMase in COS-7 cells and found that the activity of the full-length enzyme is mainly in the cells, whereas that of the truncated form is mainly in the medium. Both forms were active, but only the activity of the full-length Alk-SMase was enhanced by trypsin. By linking a poly-His tag to the constructed cDNA, we found that the first tryptic site Arg440 upstream of the signal anchor was attacked by trypsin. In conclusion, trypsin cleaves the Alk-SMase at the COOH terminal, releases it from mucosa, and meanwhile enhances its activity. The findings indicate a physiological role of trypsin in SM digestion.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0193-1857
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
287
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
G967-73
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15205117-Alkalies,
pubmed-meshheading:15205117-Animals,
pubmed-meshheading:15205117-COS Cells,
pubmed-meshheading:15205117-Cercopithecus aethiops,
pubmed-meshheading:15205117-Dose-Response Relationship, Drug,
pubmed-meshheading:15205117-Intestinal Mucosa,
pubmed-meshheading:15205117-Intestines,
pubmed-meshheading:15205117-Pancreas,
pubmed-meshheading:15205117-Peptide Fragments,
pubmed-meshheading:15205117-Rats,
pubmed-meshheading:15205117-Rats, Sprague-Dawley,
pubmed-meshheading:15205117-Sphingomyelin Phosphodiesterase,
pubmed-meshheading:15205117-Transfection,
pubmed-meshheading:15205117-Trypsin
|
pubmed:year |
2004
|
pubmed:articleTitle |
Pancreatic trypsin cleaves intestinal alkaline sphingomyelinase from mucosa and enhances the sphingomyelinase activity.
|
pubmed:affiliation |
Gastroenterology Lab, Biomedical Center B11, Lund University, S-221 84 Lund, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|